TY  - GEN
AU  - Chicaíza-Becerra,Liliana
AU  - García-Molina,Mario
AU  - Gamboa,Oscar
AU  - Castañeda-Orjuela,Carlos
TI  - ErbB2+ metastatic breast cancer treatment after progression on trastuzumab: a cost-effectiveness analysis for a developing country
SN  - 2539-3596
PY  - 2016///1010
KW  - Adult
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - economics
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Capecitabine
KW  - administration & dosage
KW  - Carcinoma, Ductal, Breast
KW  - Colombia
KW  - Cost-Benefit Analysis
KW  - Developing Countries
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Health Expenditures
KW  - Humans
KW  - Insurance, Health, Reimbursement
KW  - Lapatinib
KW  - Markov Chains
KW  - Middle Aged
KW  - Prescription Fees
KW  - Quinazolines
KW  - Receptor, ErbB-2
KW  - analysis
KW  - Taxoids
KW  - Trastuzumab
KW  - Vinblastine
KW  - Vinorelbine
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.15446/rsap.v16n2.31690
ER  -